NO20055311D0 - Farmasoytisk aktive ornitinderivater, ammoniumsalter derav og fremgangsmater for fremstilling av det samme - Google Patents

Farmasoytisk aktive ornitinderivater, ammoniumsalter derav og fremgangsmater for fremstilling av det samme

Info

Publication number
NO20055311D0
NO20055311D0 NO20055311A NO20055311A NO20055311D0 NO 20055311 D0 NO20055311 D0 NO 20055311D0 NO 20055311 A NO20055311 A NO 20055311A NO 20055311 A NO20055311 A NO 20055311A NO 20055311 D0 NO20055311 D0 NO 20055311D0
Authority
NO
Norway
Prior art keywords
preparing
processes
same
ammonium salts
pharmaceutically active
Prior art date
Application number
NO20055311A
Other languages
English (en)
Other versions
NO20055311L (no
Inventor
Andre Rosowsky
Henry Bader
Peter Blumbergs
Ming-Teh Lin
Original Assignee
Ash Stevens Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ash Stevens Inc filed Critical Ash Stevens Inc
Publication of NO20055311D0 publication Critical patent/NO20055311D0/no
Publication of NO20055311L publication Critical patent/NO20055311L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20055311A 2003-04-14 2005-11-10 Farmasoytisk aktive ornitinderivater, ammoniumsalter derav og fremgangsmater for fremstilling av det samme NO20055311L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/412,279 US6989386B2 (en) 2002-04-30 2003-04-14 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
PCT/US2004/005356 WO2004094427A1 (en) 2003-04-14 2004-02-23 Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same

Publications (2)

Publication Number Publication Date
NO20055311D0 true NO20055311D0 (no) 2005-11-10
NO20055311L NO20055311L (no) 2006-01-10

Family

ID=33309487

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055311A NO20055311L (no) 2003-04-14 2005-11-10 Farmasoytisk aktive ornitinderivater, ammoniumsalter derav og fremgangsmater for fremstilling av det samme

Country Status (12)

Country Link
US (3) US6989386B2 (no)
EP (1) EP1638973A1 (no)
JP (1) JP2006523689A (no)
KR (1) KR20060025523A (no)
AU (1) AU2004232668A1 (no)
BR (1) BRPI0409441A (no)
CA (1) CA2522538A1 (no)
MX (1) MXPA05010957A (no)
NO (1) NO20055311L (no)
RU (1) RU2005135123A (no)
WO (1) WO2004094427A1 (no)
ZA (1) ZA200508358B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
EP1513820A4 (en) * 2002-05-23 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
US20050032807A1 (en) * 2003-08-06 2005-02-10 Rosenwald Lindsay A. Methods of treating inflammatory diseases with ammonium salts of ornitihine derivatives
CA3184866A1 (en) 2020-07-06 2022-01-13 Ronald Christiaan Elgersma Antifolate linker-drugs and antibody-drug conjugates
EP4457229A1 (en) 2021-12-30 2024-11-06 Byondis B.V. Antifolate linker-drugs and antibody-drug conjugates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6023120B2 (ja) * 1979-08-13 1985-06-05 キッコーマン株式会社 アデノシン−３′，５′−環状リン酸アルキルトリエステルの製造法
US4663348A (en) * 1985-07-02 1987-05-05 Warner-Lambert Co. Furosemide salts and pharmaceutical preparations thereof
US4767761A (en) 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
US4956461A (en) 1988-10-19 1990-09-11 Dana Farber Cancer Institute, Inc. Desamino-aminopterin and -methotrexate
CH680731A5 (no) * 1990-04-12 1992-10-30 Sapec Fine Chemicals
DE4415370A1 (de) * 1994-05-02 1995-11-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
DE4438918A1 (de) * 1994-11-04 1996-05-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
JPH10310526A (ja) * 1997-05-09 1998-11-24 Iyaku Bunshi Sekkei Kenkyusho:Kk ジヒドロ葉酸還元酵素の阻害剤
KR20020008197A (ko) 1999-05-24 2002-01-29 가와무라 요시부미 항-Ｆａｓ 항체를 함유하는 의약 조성물
EP1125944A1 (de) * 2000-02-18 2001-08-22 Aventis Pharma Deutschland GmbH Pluraflavine und Derivate davon, Verfahren zu ihrer Herstellung und Verwendung derselben
JP4270483B2 (ja) * 2000-11-20 2009-06-03 第一三共株式会社 カルバペネム系抗菌剤の製造方法
DE10060677A1 (de) * 2000-12-05 2002-06-20 Aventis Pharma Gmbh Klainetine und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10111682B4 (de) * 2001-03-09 2004-03-25 Aventis Pharma Deutschland Gmbh Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung
US6989386B2 (en) 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same

Also Published As

Publication number Publication date
EP1638973A1 (en) 2006-03-29
BRPI0409441A (pt) 2006-04-18
WO2004094427A1 (en) 2004-11-04
US6989386B2 (en) 2006-01-24
US20070219204A1 (en) 2007-09-20
US20040072837A1 (en) 2004-04-15
RU2005135123A (ru) 2006-05-10
KR20060025523A (ko) 2006-03-21
AU2004232668A1 (en) 2004-11-04
MXPA05010957A (es) 2006-04-18
NO20055311L (no) 2006-01-10
US20060079531A1 (en) 2006-04-13
CA2522538A1 (en) 2004-11-04
ZA200508358B (en) 2007-03-28
JP2006523689A (ja) 2006-10-19

Similar Documents

Publication Publication Date Title
NO2017047I1 (no) Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
NO2017051I1 (no) Kariprazin, eventuelt i form av et salt, inkludert kariprazin hydroklorid
IL175953A (en) Derivatives of 3-Cycloalkylaminopyrrolidine, their Pharmaceutical Salts and Preparations Containing Them
CY2014008I2 (el) Παραγωγα κιναζολινης, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδους για την παραγωγη τους
NO2014030I2 (no) en kombinasjon av rilpivirine eller et farmasøytisk akseptabelt salt av rilpivirine innbefattende hydroklorid-saltet av rilpivirine, og emtricitabine.
AU6231801A (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
NO20054006D0 (no) Cykliske ureaderivater, fremstillingsfremgangsmate derav og farmasoytisk anvendelse av samme som kinaseinhibitorer
AU2001262318A1 (en) Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
DK1417206T3 (da) Hidtil ukendte 2H-pyridazin-3-on-derivater, farmaceutiske præparater indeholdende det samme, og en fremgangsmåde til fremstilling af den aktive bestanddel
NO20052285D0 (no) Faste, partikkelformige, antifungale preparater for farmasoytisk anvendelse
IL176872A0 (en) Amide derivatives, process for the preparation thereof and use thereof as an insecticide
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
ZA200700706B (en) Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
ZA200700709B (en) Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
IS8422A (is) Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra
IS7491A (is) Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
DK1557415T3 (da) Heterocykliske forbindelser og antitumorlægemidler indeholdende samme som den aktive ingrediens
IL175023A0 (en) Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
NO20055311D0 (no) Farmasoytisk aktive ornitinderivater, ammoniumsalter derav og fremgangsmater for fremstilling av det samme
EE200300192A (et) Guanidiini ja amidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline preparaatning eelravim
JP2004505922A5 (no)
NO20053805D0 (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
MXPA03006249A (es) Derivados de 2-arilimino-2,3-dihidrotiazoles, sus procesos de preparacion y su uso terapeutico.
HUP0201552A3 (en) Quaternary ammonium derivatives, method for preparing the same and their pharmaceutical use
NO20042022L (no) Fast legemiddelformulering som inneholder pipiperazinurea-derivat og fremgangsmate for fremstilling av formuleringen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application